Altimmune (ALT), University of Alabama at Birmingham Announce Positive Preclinical Results for Intranasal COVID-19 Vaccine Candidate, AdCOVID
Go back to Altimmune (ALT), University of Alabama at Birmingham Announce Positive Preclinical Results for Intranasal COVID-19 Vaccine Candidate, AdCOVID| iShares Diversified Alternatives Trust (NASDAQ: ALT) | Delayed: 3.41 +0.14 (4.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.27 | 52 Week High | $54.24 | |||
| Open | $3.33 | 52 Week Low | $48.35 | |||
| Day High | $3.41 | P/E | N/A | |||
| Day Low | $3.25 | EPS | $0.00 | |||
| Volume | 4,002,282 | |||||
